REVVITY, INC. — Director's Dealing 2024

Feb 7, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REVVITY, INC. (RVTY)
CIK: 0000031791
Period of Report: 2024-02-05

Reporting Person: Goldberg Joel S (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-02-05	Common Stock	M	22613	$52.65	Acquired	53500	Direct
2024-02-05	Common Stock	S	11546	$104.08	Disposed	41954	Direct
2024-02-05	Common Stock	S	3662	$104.80	Disposed	38292	Direct
2024-02-05	Common Stock	S	267	$105.66	Disposed	38025	Direct
2024-02-05	Common Stock	M	6294	$105.62	Acquired	44319	Direct
2024-02-05	Common Stock	F	1909	$105.62	Disposed	42410	Direct
2024-02-05	Common Stock	F	675	$105.62	Disposed	41735	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-05	NQ Stock Option (right to buy)	$52.65	M	22613	Disposed	2024-02-07	Common Stock (22613)	Direct
2024-02-05	NQ Stock Option (right to buy)	$104.635	A	27528	Acquired	2031-02-05	Common Stock (27528)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	63709	Indirect

Footnotes

F1: The transactions reported above in Table I include a cashless exercise of stock options. The cashless exercise for the stock options is reported in four lines. The first line of the cashless exercise transaction is coded M in column 3 of Table I and reports in column 4 the number of shares issuable upon exercise of the options had cash been paid to exercise the options, together with the exercise price with Code A for acquired. The second, third, and fourth lines coded S in column 3 of Table I relate to the same cashless exercise on the first line in Table I and report in Column 4 the number of shares sold from the total number of shares issuable to pay for the cashless exercise of such options with Code D for disposed. The transaction reported in Table II line one above,

F2: (Continued Form Footnote 1) reflects the disposition of the same stock options whose cashless exercise is disclosed in Table I above. The foregoing transactions were effected pursuant to a 10b5-1 trading plan adopted by Mr. Goldberg on August 3, 2023.

F3: The Exercise Price included on the Form 4 filed on February 8, 2017 for the Reporting Person was incorrectly reported due to administrative error.

F4: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $103.57 to $104.56. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

F5: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $104.57 to $105.47. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

F6: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $105.62 to $105.68. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

F7: Shares of common stock issued upon vesting of performance-based restricted stock units in accordance with the terms of a Performance-based Restricted Stock Unit award originally granted on February 5, 2021.

F8: These shares are being surrendered to satisfy a tax withholding obligation upon vesting of performance-based restricted stock units originally granted on February 5, 2021, as required by the Reporting Person's Performance-based Restricted Stock Unit Agreement.

F9: These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock originally granted on February 5, 2021, as required by the Reporting Person's Restricted Stock Agreement.

F10: Securities held in an irrevocable trust for the sole benefit of the reporting person's children. The reporting person's spouse is the trustee of the trust. The reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest, if any, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F11: This option became exercisable in three equal annual installments beginning on February 7, 2018, which was the first anniversary of the date on which the option was granted.

F12: This option is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant.